Mimedx (MDXG) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.22% |
| Dec 31, 2025 | 343.32% |
| Sep 30, 2025 | 79.37% |
| Jun 30, 2025 | 56.79% |
| Mar 31, 2025 | 46.22% |
| Dec 31, 2024 | 41.21% |
| Sep 30, 2024 | 35.54% |
| Jun 30, 2024 | 46.76% |
| Mar 31, 2024 | 32.35% |
| Dec 31, 2023 | 23.51% |
| Sep 30, 2023 | -56.43% |
| Jun 30, 2023 | -16.61% |
| Mar 31, 2023 | -17.49% |
| Dec 31, 2022 | -17.54% |
| Sep 30, 2022 | -16.40% |
| Jun 30, 2022 | -15.91% |
| Mar 31, 2022 | -15.52% |
| Dec 31, 2021 | -72.05% |
| Sep 30, 2021 | -15.41% |
| Jun 30, 2021 | -15.54% |
| Mar 31, 2021 | -15.67% |
| Dec 31, 2020 | -14.92% |
| Sep 30, 2020 | -33.71% |
| Jun 30, 2020 | -24.51% |
| Mar 31, 2020 | -18.89% |
| Dec 31, 2019 | -17.38% |
| Sep 30, 2019 | -13.40% |
| Jun 30, 2019 | -19.82% |
| Mar 31, 2019 | -12.84% |
| Dec 31, 2018 | -7.56% |
| Sep 30, 2018 | 18.97% |
| Jun 30, 2018 | 19.80% |
| Mar 31, 2018 | 18.96% |
| Dec 31, 2017 | 29.83% |
| Sep 30, 2017 | 49.34% |
| Jun 30, 2017 | 56.54% |
| Mar 31, 2017 | 59.51% |
| Dec 31, 2016 | 32.21% |
| Sep 30, 2016 | 59.74% |
| Jun 30, 2016 | 56.57% |
| Dec 31, 2015 | 41.60% |